Skip navigation

Iroko Pharma cancels IPO, citing timing

Iroko Pharmaceuticals Inc. said Wednesday it will not pursue its planned initial public offering. Full story

India's Strides responds to FDA, continues shipments to U.S

MUMBAI (Reuters) - Strides Arcolab, the latest Indian drug firm to draw U.S. regulators' scrutiny over manufacturing practices, has answered June queries by the U.S. Food and Drug Administration on its drug factories, the firm's chief executive said on Wednesday. Full story

Sanofi allergy drug safe enough for non-prescription use: FDA reviewers

WASHINGTON (Reuters) - Sanofi SA's allergy drug Nasacort AQ is safe enough to be sold over the counter, according to reviewers for the U.S. Food and Drug Administration. Full story

Court overturns patents on Teva's MS drug Copaxone

Two drug companies said Friday that they hope to start selling a generic version of the multiple sclerosis treatment Copaxone in May after a federal appeals court overturned several patents supporting the drug. Full story

Forest Labs says FDA approves depression drug

Forest Laboratories Inc. said Friday that the Food and Drug Administration has approved its depression drug Fetzima, and the drug should be available in the fourth quarter. Full story

CFT: After three-year suspension, Georgia OL reinstated by NCAA

Finally, Kolton Houston will get to play football for the Georgia Bulldogs. The offensive lineman has been serving a suspension since 2010, his first year in Athens, because he tested positive for 19-Norandrosterone, a drug on the NCAA’s banned substance list. According to a previous report from the Full story

Sponsored Links

Articles

WCI, largest of Thursday's IPOs, raises $102M

Mass. slaying suspect faces arraignment

Orion, Mylan settle patent dispute over Parkinson's drug Stalevo

Transition Therapeutics acquires rights to Lilly's arthritis drug

FDA can't allow execution drug to be imported

HBT: Before you climb aboard the “we should void cheaters’ contracts!” express …

Supreme Court win boosts fight against drug settlements: FTC

Ironwood Pharma 2Q loss widens, revenue slides

Waters 2Q profit drops 9 pct, order slowdown hurts

Monday's Sports In Brief

Video

  Sprinter Tyson Gay fails drug test

The 30-year-old American sprinter said he will be pulling out of the world championships after failing a drug test for a banned substance.

  Hollywood tackles America's drug trade

Adrien Grenier and Matthew Cooke join The Cycle to talk about "How to Make Money Selling Drugs," a new documentary that looks at the tactics and techniques of drug dealers.

  Men allegedly steal hundreds of watermelons

Police in Oregon allege two men stole thousands of pounds of watermelons, with the intent to sell them to someone, to support their drug habit. KGW's Mike Benner reports.

  Cops accused of brutality say suspect choked on drugs

Deputies in Bakersfield, Calif., say a suspect in thier custody died choking on drugs, but his family maintains plastic baggies found in Willie Ramos’ throat were part of a coverup in a case of police brutality. KCRA’s Katey Rusch reports.

  Supreme Court Rules on 'Pay for Delay'

The FTC can challenge deals to keep generic drugs off the market, reports CNBC's Hampton Pearson.

advertisement | ad info

Related Photos

The logo of drugs and chemicals group Merck is pictured at one of its branches in central German city of Darmstadt in this file photo
The logo of drugs and chemicals group Merck is pictured at one of its branches in central German city of Darmstadt in this file photo

The logo of drugs and chemicals group Merck is pictured at one of its branches in central German city of Darmstadt in this file photo from March 7, 2012. REUTERS/Alex Domanski/Files

A logo of Swiss drug industry supplier Lonza is pictured outside the company's quarters in Visp October 31, 2012. REUTERS/Ruben Sprich
A logo of Swiss drug industry supplier Lonza is pictured outside the company's quarters in Visp October 31, 2012. REUTERS/Ruben Sprich

A logo of Swiss drug industry supplier Lonza is pictured outside the company's quarters in Visp October 31, 2012. REUTERS/Ruben Sprich

The logo of Belgian drug, chemical, and plastics group UCB is seen at the entrance of the company's headquarters in Brussels March 2, 2010.
The logo of Belgian drug, chemical, and plastics group UCB is seen at the entrance of the company's headquarters in Brussels March 2, 2010.

The logo of Belgian drug, chemical, and plastics group UCB is seen at the entrance of the company's headquarters in Brussels March 2, 2010. REUTERS/Yves Herman

Man fights insurer for life-saving drug